AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37

Authors: STALLARD S LITHERLAND J CORDINER C MALLON E DOBSON H GEORGE WD HOLE DJ
Citation: S. Stallard et al., HORMONE REPLACEMENT THERAPY DOES NOT INFLUENCE PATHOLOGICAL STAGE OF BREAST-CANCER IN 1113 TUMORS, European journal of cancer, 34, 1998, pp. 382-382

Authors: ANDERSON T TYACK C ADAMSON R MALLON E MCPHIE J MILLER I ROBERTSON A LAMB J MCKEAN M NICOLL S WARNER J EDINBURGH O
Citation: T. Anderson et al., USING A PATHOLOGY DATABASE IN BREAST-CANCER SCREENING EVALUATION, Journal of pathology, 186, 1998, pp. 6-6

Authors: MALLON E BUNCE M SAVOIE H GOTCH F BUNKER CB
Citation: E. Mallon et al., HLA-CW-ASTERISK-0602 AND GUTTATE PSORIASIS, Journal of investigative dermatology, 110(4), 1998, pp. 618-618

Authors: ROWE A MALLON E ROSENBERGER P BARRETT M WALSH J BUNKER CB
Citation: A. Rowe et al., DECREASES IN CUTANEOUS PEPTIDERGIC INNERVATION IN HIV-ASSOCIATED XEROSIS, Journal of investigative dermatology, 110(4), 1998, pp. 667-667

Authors: CHONG D REEVES J COOKE T GEORGE WD MALLON E OZANNE B STANTON P
Citation: D. Chong et al., EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERBB2 EXPRESSION IN BREAST-CANCER PROGRESSION, British Journal of Surgery, 85(11), 1998, pp. 1570-1571

Authors: MALLON E YOUNG D BUNCE M GOTCH FM EASTERBROOK PT NEWSON R BUNKER CB
Citation: E. Mallon et al., HLA-CW-ASTERISK-0602 AND HIV-ASSOCIATED PSORIASIS, British journal of dermatology, 139(3), 1998, pp. 527-533

Authors: CHONG D REEVES J COOKE T GEORGE WD MALLON E OZANNE B STANTON P
Citation: D. Chong et al., QUANTITATION OF C-ERBB-2 IN PRIMARY BREAST-CANCER - GENE AMPLIFICATION IS NOT THE WHOLE PICTURE, British Journal of Cancer, 78, 1998, pp. 70-70

Authors: CHONG D REEVES J COOKE T GEORGE WD MALLON E OZANNE B STANTON P
Citation: D. Chong et al., EGFR AND C-ERBB-2 EXPRESSION IN BREAST-CANCER PROGRESSION, British Journal of Cancer, 78, 1998, pp. 71-71

Authors: CHONG D REEVES J COOKE T GEORGE WD MALLON E OZANNE B STANTON F
Citation: D. Chong et al., QUANTITATION OF EGFR AND C-ERBB-2 EXPRESSION IN PREINVASIVE COMPARED TO INVASIVE BREAST-CANCER, British Journal of Cancer, 78, 1998, pp. 176-176

Authors: CHONG D REEVES J COOKE T GEORGE WD MALLON E OZANNE B STANTON P
Citation: D. Chong et al., QUANTITATION OF C-ERBB-2 IN PRIMARY BREAST-CANCER ALLOWS IDENTIFICATION OF A FURTHER POOR PROGNOSTIC GROUP, British Journal of Cancer, 78, 1998, pp. 177-177

Authors: MALLON E DAWBER R
Citation: E. Mallon et R. Dawber, WHAT OF THE CLINICAL-SIGNIFICANCE OF THE CRYOIMMUNE RESPONSE - REPLY, Dermatologic surgery, 23(6), 1997, pp. 500-500

Authors: MALLON E ROSS JS HAWKINS DA DINNEEN M FRANCIS N BUNKER CB
Citation: E. Mallon et al., BIOPSY OF MALE GENITAL DERMATOSES, Genitourinary medicine, 73(5), 1997, pp. 421-421

Authors: MALLON E MCKEE PH
Citation: E. Mallon et Ph. Mckee, EXTRAORDINARY CASE-REPORT - CUTANEOUS ANTHRAX, The American journal of dermatopathology, 19(1), 1997, pp. 79-82

Authors: MALLON E BUNCE M WOJNAROWSKA F WELSH K
Citation: E. Mallon et al., HLA-CW-ASTERISK-0602 IS A SUSCEPTIBILITY FACTOR IN TYPE-I PSORIASIS, AND EVIDENCE ALA-73 IS INCREASED IN MALE TYPE-I PSORIATICS, Journal of investigative dermatology, 109(2), 1997, pp. 183-186

Authors: MACMILLAN RD PURUSHOTHAM AD MALLON E LOVE JG GEORGE WD
Citation: Rd. Macmillan et al., TUMOR BED POSITIVITY PREDICTS OUTCOME AFTER BREAST-CONSERVING SURGERY, British Journal of Surgery, 84(11), 1997, pp. 1559-1562

Authors: MALLON E BUNKER C
Citation: E. Mallon et C. Bunker, MRCP - SLIDES IN DERMATOLOGY .2., British Journal of Hospital Medicine, 57(6), 1997, pp. 262-264

Authors: MALLON E BUNKER C
Citation: E. Mallon et C. Bunker, SLIDES IN DERMATOLOGY .1., British Journal of Hospital Medicine, 57(4), 1997, pp. 159-161

Authors: MALLON E POWELL S MORTIMER P RYAN TJ
Citation: E. Mallon et al., EVIDENCE FOR ALTERED CELL-MEDIATED-IMMUNITY IN POSTMASTECTOMY LYMPHEDEMA, British journal of dermatology, 137(6), 1997, pp. 928-933

Authors: NEWTON JN MALLON E KLASSEN A RYAN TJ FINLAY AY
Citation: Jn. Newton et al., THE EFFECTIVENESS OF ACNE TREATMENT - AN ASSESSMENT BY PATIENTS OF THE OUTCOME OF THERAPY, British journal of dermatology, 137(4), 1997, pp. 563-567

Authors: WILLIAMS F MALLON E MIDDLETON D
Citation: F. Williams et al., DEVELOPMENT OF PCR-SSOP FOR HLA-A TYPING OF BONE-MARROW REGISTRY DONORS, Tissue antigens, 49(1), 1997, pp. 61-66

Authors: MALLON E DAWBER R
Citation: E. Mallon et R. Dawber, CRYOSURGERY IN THE TREATMENT OF BASAL-CELL CARCINOMA - ASSESSMENT OF ONE AND 2 FREEZE-THAW CYCLE SCHEDULES, Dermatologic surgery, 22(10), 1996, pp. 854-858

Authors: NAGY J CURRY GW HILLAN KJ MALLON E PURUSHOTHAM AD GEORGE WD
Citation: J. Nagy et al., HEPATOCYTE GROWTH-FACTOR SCATTER FACTOR, ANGIOGENESIS AND TUMOR-CELL PROLIFERATION IN PRIMARY BREAST-CANCER, Breast, 5(2), 1996, pp. 105-109

Authors: NAGY J CURRY GW HILLAN KJ MCKAY IC MALLON E PURUSHOTHAM AD GEORGE WD
Citation: J. Nagy et al., HEPATOCYTE GROWTH FACTOR SCATTER FACTOR EXPRESSION AND C-MET IN PRIMARY BREAST-CANCER/, Surgical oncology, 5(1), 1996, pp. 15-21

Authors: DRUDY L MCCAFFREY M MALLON E HARRISON R
Citation: L. Drudy et al., SPERMATOZOAL DNA FLOW-CYTOMETRY AND RECURRENT MISCARRIAGE, Archives of andrology, 37(3), 1996, pp. 143-147

Authors: BISSETT D MALLON E REED NS GEORGE WD HARNETT AN
Citation: D. Bissett et al., CYSTOSARCOMA-PHYLLOIDES - HETEROGENEITY IN A RARE TUMOR TYPE, Journal of the Royal College of Surgeons of Edinburgh, 41(4), 1996, pp. 244-245
Risultati: 1-25 | 26-37